HBEL stands for Health-Based Exposure Limit. It is a scientifically and toxicologically derived value that represents the maximum daily dose of a substance (typically an active pharmaceutical ingredient, intermediate, or cleaning agent) to which an individual can be exposed every day over a lifetime without experiencing adverse effects.
​In modern pharmaceutical manufacturing and cleaning validation (governed by EMA Annex 15, PIC/S PI 046, and ICH Q9/Q3C), HBEL values replace arbitrary blanket limits (like 10 ppm or 0.001 of a minimum therapeutic dose) to assess cross-contamination risks in multi-product facilities.
​The Terminology: HBEL vs. PDE vs. ADE
​While HBEL is the overarching regulatory concept, the actual numerical values used in cleaning calculations are expressed as:
- PDE (Permitted Daily Exposure): Primarily used in European (EMA) and international (ICH, PIC/S) guidelines. Measured in mg/day or g/day.
- ​ADE (Acceptable Daily Exposure): Commonly used in US FDA and ISPE Risk-MaPP guidelines. Mathematically and conceptually identical to PDE.
1. Point of Departure (PoD)
NOAEL (No Observed Adverse Effect Level): The highest dose tested in animal or human clinical studies at which no statistically significant adverse effect is observed.
LOAEL (Lowest Observed Adverse Effect Level): Used if a clear NOAEL cannot be established (requires an additional adjustment factor).
2. Body Weight
Standard reference weight for an adult human is typically assumed to be 50 kg (EMA guideline) or 60kg (some occupational/ICH frameworks).
3. Safety/Uncertainty Factors (F1 through F5)
F1 (Interspecies extrapolation): Adjusts for animal-to-human metabolic differences (e.g., F1 = 5 for rats, 12 for mice, 2 for dogs)
F2 (Inter-individual variability): Accounts for differences between sensitive populations (children, elderly) and standard adults (typically defaulted to 10).
F3 (Study duration): Adjusts for short-term/sub-chronic studies extrapolating to lifetime chronic exposure (e.g., 1 for 2-year studies, up to 10 for short studies).
F4 (Toxicity severity): Applied if severe toxicity (e.g., teratogenicity, reproductive toxicity, non-genotoxic carcinogenicity) is observed (values range from 1 to 10).
F5 (LOAEL to NOAEL): Applied (up to 10) when only a LOAEL is available instead of a true NOAEL.
Role in Cleaning Validation
Once the toxicologist determines the PDE mg/day, QA uses it to calculate the Maximum Allowable Carryover (MAC) into the next manufacturing batch:
Facility Facility & Dedication Decision Tree
Under revised GMP rules (e.g., EMA Chapter 3 and Chapter 5):
PDE > 10g/day: Standard cross-contamination risk management; products can typically share equipment with validated cleaning procedures.PDE < 10 g/day: Highly hazardous / potent compounds; requires stringent organizational and technical controls (e.g., dedicated HVAC, barrier isolators, campaign manufacturing).
Genotoxic carcinogens without a threshold or extreme sensitizers (e.g., certain \beta-lactams): An HBEL cannot be safely derived, necessitating dedicated, segregated facilities.